21 CFR §522.1260
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
- (a)Specifications. Each milliliter of solution contains lincomycin hydrochloride monohydrate equivalent to:
- (b)Sponsors. See sponsors in § 510.600(c) of this chapter for uses as in paragraph (e) of this section.
- (1)No. 054771 for use of concentrations in paragraph (a)(1) of this section as in paragraph (e) of this section.
- (2)Nos. 016592 and 058005 for use of concentrations in paragraph (a)(2) of this section as in paragraph (e)(2) of this section.
- (3)No. 054771 for use of concentration in paragraph (a)(3) of this section as in paragraph (e)(2) of this section.
- (4)No. 061133 for use of concentrations in paragraph (a)(4) of this section as in paragraph (e)(2) of this section.
- (c)Special considerations. When common labeling for use of the drug in dogs, cats, and swine is included with the drug, all such uses are subject to the labeling requirements of § 201.105 of this chapter.
- (d)Related tolerances. See § 556.360 of this chapter.
- (e)Conditions of use. It is used for animals as follows:
- (1)Dogs and cats—(i) Amount. 5 mg per pound (/lb) of body weight twice daily or 10 mg/lb body weight once daily by intramuscular injection; 5 to 10 mg/lb body weight one or two times daily by slow intravenous injection.
- (2)Swine—(i) Amount. 5 mg/lb body weight once daily by intramuscular injection for 3 to 7 days.